Only first 10,000 results will be saved in the file.
No item is selected. Use checkboxes to select search results.
Displaying 76-100 of 1083 results.
{{ selectedCountPage }} items selected on this page,{{ selectedCountPage }} item selected on this page,{{ selectedCountTotal }} item in total{{ selectedCountTotal }} items in total
life and life expectancy of patients with COVID-19 in Isfahan city in 2022
Design:
The clinical trial has a control group with single blind and randomized parallel groups on 40 patients with COVID-19 and (...) office of Dr morteza Pourahmad(specializing in infectious diseases),during which 40 patients of COVID-19
Study aim:
Determining the effect of patient education through social media on COVID-19-related (...) ability to use a smartphone, tablet,or laptop
4- Not being infected by COVID-19
5- Granting written (...) the COVID-19 nature, causes, and symptoms of the disease, pharmacological treatment and correct use of
against COVID-19 infection
Determination of the number and function of lymphocytes along with the average (...) consent form, Both genders from 20 to 50 years old, Definite infection of COVID-19
Exclusion criteria:
Age (...) group is the group that is currently suffering from COVID-19 and receiving Annual SZ drug. The control
moderate COVID-19
Design:
A randomized clinical trial, case-control, parallel with a cross-sectional (...) therapy.
Participants/Inclusion and exclusion criteria:
Including criteria are confirmed COVID-19, based on reverse transcriptase-polymerase chain reaction, mild to moderate COVID-19, and within 48 hours of
respiratory distress caused by Covid-19 disease. After the researchers explain the goals of the project, the (...) for Covid-19 in the ICU
Treatment group: Receiving common drugs for for Covid-19 in the ICU + a dose
treatment of hospitalized patient with COVID-19
Design:
This study is a two arm parallel group, single blinded clinical trial, randomized, phase 2-3 which will be carried out on 140 hospitalized COVID-19 patients.
Settings and conduct:
140 hospitalized COVID-19 patients in Shahr-e-Kord Hajar hospital
Study aim:
Use of probiotics to prevent the symptoms of Covid-19 in families where one of the members has Covid-19 disease
Design:
This single-center study was in coordination with Keyvna Laboratory (...) 63 years
6- No prognostic signs of Covid disease-19 two weeks before the study
7- No documented
individuals in the family of under treatment Covid19 patients
Design:
The present study is a randomized (...) , participants will be monitored for clinical symptoms and COVID-19. and a questionnaire approved by infectious (...) criteria:
Inclusion criteria for participants are: Definitive diagnosis of Covid19 for a member of family
cell status in patients with COVID-19
Design:
This study will be a randomized double-blind randomized controlled clinical trial with 40 patients with COVID-19. The subjects will be assigned to the intervention (...) criteria:
Inclusion criteria:
1. Being 20 to 65 years old 2. Detection of COVID-19 based on PCR test 3
Study aim:
Evaluation of Dexamethasone effects on improvement of Iranian COVID-19 patients (...) second phase. Which will be performed on 200 outpatients with COVID-19 disease. Patients are randomly (...)COVID-19 with respiratory symptoms referred to clinics in Imam Khomeini, Amir-Alam, Emam Ali and Ziaian
Study aim:
Evaluation of slow release mucoadhesive paste of” Mucodentol “ on symptoms of COVID-19 disease in non infected family members of infected patients by COVID-19
Design:
Clinical trial with (...) -blind clinical trial is performed on the covid-19 patient's companions. 600 family members of coronary
C and N-acetyl cysteine in the treatment of COVID19 patients
Design:
A randomized, controlled trial, based on patients with Covid-19, which has two parallel groups.
Settings and conduct:
Imam Reza Hospital
confirmed case of Covid-19 by RT-PCR on the nasopharyngeal swab collected or clinical and HR-CT
Study aim:
Considering the role of inflammatory cytokines in COVID-19 disease and its severity (...) no control group and no blindness on 10 hospitalized patients with severe forms of COVID-19(...) , Mazandaran with severe forms of COVID-19 who no improvement was observed in their disease course despite
Study aim:
Assessing the effect of surfactant on clinical outcome in patients with Covid-19 under (...) assessment
Settings and conduct:
COVID-19 patients under mechanical ventilation would enter the study; one (...) confirmed COVID-19
Exclusion criteria:
Existence of a major underlying pulmonary disease in addition to
prescribed a standard regimen for COVID-19. The intervention group will be prescribed by intravenous immunoglobulin 100-200 mg oral two times daily for two days and a standard regimen for COVID-19. CT scan of lungs (...)
Intervention groups:
Intervention group: will receive a standard regimen for COVID-19 plus intravenous
Study aim:
Determining effect of Convalescent Plasma on COVID-19 patients Outcome: A Randomised (...) patients, about 450 ml of the received plasma will be transferred to the COVID-19 patients hospitalized in (...) criteria:
Recipient:
1- COVID-19 Patients
2- Consent to attend the study
3. Age 30 to 70 years
4- Don't be
Study aim:
Evaluation of the effect of a herbal compound on patients with clinical and CT scan findings strongly suspected of COVID-19
Design:
This study is a randomized controlled clinical trial in (...) :
Hospitalized patients who are suspected to COVID- 19 based on clinical symptoms and computed tomography
Study aim:
Evaluating the effectiveness of Ozone therapy in improving patient outcomes in COVID-19(...) trial which will be conducted on 80 Covid-19 patients.
Settings and conduct:
COVID-19 patients who (...) exclusion criteria:
Inclusion criteria: Patients who have been diagnosed with Covid-19.
Non-inclusion
Study aim:
Efficacy of hydroxychloroquine in prevention of sever forms of COVID-19 Disease will be (...) for 10 weeks.
The participants who caught COVID-19 during the study period will be followed until the (...) ) affiliated hospitals
Age 18-70 y and no symptoms of COVID-19 at the time of registration
Desire to
Study aim:
Assessment of effects of Bosentan therapy on outcomes of outpatients with COVID-19(...) , laboratory-confirmed COVID-19 illness, who are at high risk for progression to severe/critical illness, but (...) symptoms of COVID-19 illness and laboratory-confirmed SARS-CoV-2 determined by PCR assay < 72 hours prior
hospitals for hospitalized Covid-19 patients affiliated to Isfahan University of Medical Sciences.
Participants/Inclusion and exclusion criteria:
Inclusion criteria:
Age 18 years or older
Diagnosis of COVID-19(...) ventilation
Intervention groups:
Intervention group: In addition to the essential treatment for COVID-19, one
in people who were in close contact with patients with COVID-19 disease hospitalized in Bushehr (...)COVID-19 who has been diagnosed positive with a definitive test.
Intervention groups:
After obtaining (...) effect of oral hydroxy-chloroquine in close contacts of COVID-19 patients
Study aim:
To assess the effect of plasma of patients recovered from covid-19 versus control group on treatment of covid-19
Design:
This is a randomized clinical trial, phase II, in which 100 (...) of 18 to 65 years,
Moderate to severe covid-19 disease,
Exclusion criteria:
Pregnancy,
IGA
Study aim:
The comparisson of the prevalence and the severity of COVID-19 in staff with encounter (...) trial with outcome assessment in 320 volunteer staff who encounter with COVID-19 patients divided into (...) in Isfahan city who are an encounter with COVID-19 patients divided into the case (weekly use of
clinical outcomes and immune response in COVID-19 patients.
Design:
A double-blind randomized controlled (...) with the criteria of being infected with COVID-19 after being admitted to the Corona Ward of Tehran (...) .
Participants/Inclusion and exclusion criteria:
Hospitalized patients diagnosed with COVID-19
Intervention